A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)

NCT05625919 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)

Interventions

DRUG: Sirolimus for Injection (Albumin Bound)

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.